Articles by Rita Peters - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Rita Peters

Contract Providers Assume Expanded Responsibilities

Sep 1, 2014

Contract service providers are playing a more diverse role in drug development.

Meeting the Challenges of Excipient Variability

Sep 1, 2014

The quality and composition of excipients can vary due to environmental factors, processing methods, raw material quality, manufacturing location changes, and even operator actions.

API Developers Pass Inspections and Upgrade Capabilities

API development and manufacturing companies expanded their capabilities, built partnerships, and achieved milestones in regulatory inspections.
Sep 1, 2014

API development and manufacturing companies expanded their capabilities, built partnerships, and achieved milestones in regulatory inspections.

A Silver Milestone for Drug Development

Pharmaceutical Technology Europe marks 25 years of drug-development advances.
Aug 2, 2014

Pharmaceutical Technology Europe marks 25 years of drug-development advances.

Shifting Gears in Drug Development Outsourcing Responsibilities

Aug 1, 2014

For a bio/pharma industry in flux, contract services are playing a greater—and more diverse—role in drug development.

Benefits and Risks of Drug Information on Social Media

Jul 2, 2014

FDA draft guidances seek to maintain accurate drug information for patients in new media.

US Biopharma Worries About Losing Lead in Innovation

Changes are needed to maintain US biopharma innovation leadership.
May 2, 2014

Changes are needed to maintain US biopharma innovation leadership.

Biopharma Takes a Nervous Glance Over Its Shoulder

Changes are needed to maintain US biopharma innovation leadership.
May 2, 2014

Changes are needed to maintain US biopharma innovation leadership.

Publishing Beyond the Printed Page

Apr 2, 2014

More media options open publishing opportunities for drug development experts.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here